Choksi Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 526546 | NSE: | Hospital & Healthcare Services | Small Cap

Choksi Lab Share Price

42.25 0.79 1.91%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Choksi Lab

M-Cap below 100cr DeciZen not available

Choksi Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
8.65
Market Cap:
29.5 Cr.
52-wk low:
30.6
52-wk high:
86

Is Choksi Laboratories Ltd an attractive stock to invest in?

1. Is Choksi Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Choksi Laboratories Ltd is a average quality company.

2. Is Choksi Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Choksi Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Choksi Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Choksi Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Choksi Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Choksi Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 6.6%5.3%5.1%5.1%7.4%7.1%-0.8%-1.2%4.6%7.8%-
Value Creation
Index
-0.5-0.6-0.6-0.6-0.5-0.5-1.1-1.1-0.7-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 19.92222.328.831.233.828.225.73034.435
Sales YoY Gr.-10.5%1.5%29%8.5%8.2%-16.6%-8.8%16.9%14.7%-
Adj EPS 1.60.81.20.91.92.3-2.4-3.70.32.34.9
YoY Gr.--50.9%45%-20.7%110.9%18%-206.1%NANA673.3%-
BVPS (₹) 29.227.728.830.332.234.52925.525.730.331.1
Adj Net
Profit
1.10.60.80.61.41.6-1.7-2.60.21.63
Cash Flow from Ops. 3.82.36.76.66.36.92.95.97.98.3-
Debt/CF from Ops. 35.121.722.4116.14.43.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.3%2%6.9%14.7%
Adj EPS 4%3.6%NA673.3%
BVPS0.4%-1.2%1.5%17.9%
Share Price 22.4% 25.6% 78.7% 34.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
5.82.84.13.16.26.9-7.7-13.71.28.316
Op. Profit
Mgn %
21.723.423.316.620.321.512.616.129.729.829.1
Net Profit
Mgn %
5.72.53.62.24.34.7-6-10.10.74.79.7
Debt to
Equity
0.60.60.70.50.60.71.621.91.4-
Working Cap
Days
211222244181149174221219171150100
Cash Conv.
Cycle
888165261385194472-7

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 16.00%

Debt to equity has declined versus last 3 years average to 1.44

Sales growth has been subdued in last 3 years 6.94%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 1.67%

Latest Financials - Choksi Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 4.9 -
TTM Sales (₹ Cr.) 35.3 -
BVPS (₹.) 31.1 -
Reserves (₹ Cr.) 15 -
P/BV 1.36 -
PE 8.65 -
From the Market
52 Week Low / High (₹) 30.62 / 86.00
All Time Low / High (₹) 0.50 / 98.35
Market Cap (₹ Cr.) 29.5
Equity (₹ Cr.) 7
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Choksi Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Choksi Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales19.8921.9722.3028.7631.2033.7528.1625.6930.0434.44
Operating Expenses 15.5716.8417.2223.9824.8726.4825.3221.5621.1424.18
Manufacturing Costs2.582.872.773.373.923.823.883.753.544.33
Material Costs2.422.802.822.973.473.953.242.571.982.21
Employee Cost 6.7177.298.7610.5111.4711.7010.7811.0412
Other Costs 3.874.174.338.876.977.246.504.464.575.63
Operating Profit 4.315.135.084.786.337.262.844.138.9110.26
Operating Profit Margin (%) 21.7%23.4%22.8%16.6%20.3%21.5%10.1%16.1%29.6%29.8%
Other Income 0.100.640.010.860.360.250.330.490.120.22
Interest 1.191.571.231.471.591.541.892.823.233.52
Depreciation 1.592.832.732.863.163.684.564.605.435.50
Exceptional Items 000000-2.43002.26
Profit Before Tax 1.631.381.141.311.932.29-5.71-2.810.373.72
Tax 0.460.500.420.420.590.69-1.83-0.200.160.51
Profit After Tax 1.170.880.720.891.351.60-3.88-2.610.213.21
PAT Margin (%) 5.9%4.0%3.2%3.1%4.3%4.7%-13.8%-10.2%0.7%9.3%
Adjusted EPS (₹)1.71.31.01.31.92.3-5.6-3.70.34.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 20.3119.3120.0321.1322.4024.0120.2217.7517.9021.11
Share Capital 6.976.976.976.976.976.976.976.976.976.97
Reserves 13.3512.3513.0714.1615.4317.0413.2610.7810.9414.14
Minority Interest0000000000
Debt8.948.5710.898.039.8615.1229.8531.2930.0325.21
Long Term Debt6.285.618.064.275.521427.3628.8227.5423.61
Short Term Debt2.672.962.823.764.341.122.492.482.491.59
Trade Payables1.652.684.014.815.657.156.424.834.021.80
Others Liabilities 7.807.117.606.686.779.077.1410.9811.0811.37
Total Liabilities 38.7137.6742.5340.6644.6855.3563.6364.8563.0359.49

Fixed Assets

Gross Block34.0727.5128.5222.4331.6544.4845.9467.5668.7170.94
Accumulated Depreciation10.098.2210.882.866.039.6812.8617.2422.1526.11
Net Fixed Assets23.9819.2817.6419.5625.6334.8133.0850.3246.5644.83
CWIP 2.232.738.994.2803.2313.060.501.670.31
Investments 0002.672.9900000
Inventories0000.230.290.410.180.110.250.21
Trade Receivables7.128.458.588.809.888.796.998.1610.2910.65
Cash Equivalents 0.610.820.920.560.950.230.430.310.410.34
Others Assets4.776.386.394.554.947.899.905.443.853.15
Total Assets 38.7137.6742.5340.6644.6855.3563.6364.8563.0359.49

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 3.772.306.716.576.256.912.875.907.888.25
PBT 1.631.381.141.311.932.29-5.71-2.810.373.72
Adjustment 2.693.7643.674.294.997.086.938.726.90
Changes in Working Capital 0.9-2.423.370.931.662.682.57-1.34-2.39-3.11
Tax Paid -1.44-0.42-1.800.66-1.64-3.07-1.073.111.170.74
Cash Flow From Investing Activity -6.10-0.73-7.40-1.88-4.91-9.76-13.76-7.65-2.71-0.71
Capex -4.020.49-1.15-2.28-4.83-6.51-1.44-7.54-1.13-0.89
Net Investments 0000-0.3200000.01
Others -2.09-1.22-6.250.400.24-3.25-12.33-0.10-1.580.17
Cash Flow From Financing Activity 1.31-1.370.80-4.89-0.942.1311.091.63-5.07-7.61
Net Proceeds from Shares 0.324.3500000000
Net Proceeds from Borrowing 3.05-4.442.16-3.420.653.6713.394.73-1.46-3.51
Interest Paid -1.19-1.57-1.23-1.47-1.59-1.54-1.89-2.77-3.21-3.49
Dividend Paid 0000000000
Others -0.860.29-0.14000-0.41-0.32-0.40-0.61
Net Cash Flow -1.020.210.11-0.200.40-0.720.20-0.120.10-0.07
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)5.954.453.674.346.196.9-17.57-13.741.1616.46
ROCE (%)9.429.397.328.4110.4910.14-8.270.026.7513.9
Asset Turnover Ratio0.540.580.560.690.830.670.470.40.470.56
PAT to CFO Conversion(x)3.222.619.327.384.634.32N/AN/A37.522.57
Working Capital Days
Receivable Days12312913911097101102108112111
Inventory Days0003344222
Payable Days200282432541550592764801814480

Choksi Laboratories Ltd Stock News

Choksi Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Choksi Lab on 28-Mar-2024 16:01 is ₹42.25.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Choksi Lab stood at ₹29.52.
The latest P/E ratio of Choksi Lab as of 28-Mar-2024 16:01 is 8.65.
The latest P/B ratio of Choksi Lab as of 28-Mar-2024 16:01 is 1.36.
The 52-week high of Choksi Lab is ₹86.00 and the 52-week low is ₹30.62.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Choksi Lab is ₹35.27 ( Cr.) .

About Choksi Laboratories Ltd

Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

CLL is a contract testing and analysis laboratory based in Indore, Central India. It analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals etc. It also help industries in their research processes. Its environment consultancy division helps firms in keeping the environment clean and free from pollution.

CLL was the first to develop Vendor Assessment programme in the edible oil extraction industry. The first to start water and soil analysis in Central India, also the first to start instrument calibration services for organizations that were targeting ISO certification or had already achieved it. The only one to commission and run, probably the largest Effluent Treatment Plant in India, at ONGC's Amod oil rig.

Quality products are a function of better raw materials and quality procedures.  CLL currently has facilities for analysis of over 1000 products and materials, with more being added every day.

A vast updated database of test specifications derived from AOAC, USP, BP, CP, EP, IP, IS, EPA, PFA, Food Chemicals Codex, AOCS, and several in-house methods, serves a wide spectrum of products and materials – pharmaceutical raw materials and formulations, agro products and their derivatives, fertilizers, pesticides, edible and industrial oils, chemicals, paints and dyes.

Last year, CLL provided its services to more than 1,000 customers world-wide. Driving this accelerated growth is a hard-working people-force of 200+ CLL personnel. They are young (The average age in CLL is below 30 years). They are determined. And they have a huge appetite for learning. Mostly from the University town of Indore, these graduates undergo a rigorous six month training at their lab. Once inducted, continuous training programmes take over - both internal as well as external. And finally the long painful process of getting these qualified personnel approved as FDA, BIS, MoEF - whatever their respective fields demand. In fact, one thing that they are quite known for is their excellent human resource pool. So much so that the surrounding companies keep playing bait to our experienced staff. Though it is quite a nuisance at times, it also does us proud when they are recognized and accepted in regional companies, and multinationals alike.

Services offered by the company:

  • Contract Laboratory Services (CLS):-Pharmaceutical Analysis-Food & Beverages Analysis-Water Analysis-Construction Material Analysis
  • Instrument Calibration & Validation Services
  • Environment Management Services
  • Clinical Research
  • Consultancy  
  • Assaying & Hallmarking

Clientele:

  • IPCA Laboratories
  • Nicholas Piramal India Ltd.
  • Serum Institute of India
  • Famycare India

Achievements/ recognition:

  • CLL is certified by BIS (Bureau of Indian Standards), FDA (Food and Drugs control Administration), MoEF (Ministry of Environment & Forests), State Pollution Control Boards (Gujarat and Madhya Pradesh State Pollution Control Boards), Department of Health(MP), Agricultural Marketing Advisor (AGMARK - GOI), and several other regulatory bodies.
  • CLL has also been accredited by NABL (National Accreditation Board for testing & calibration Laboratories). This is internationally recognized through ILAC (International Laboratory Accreditation Committee) and is based on ISO/IEC 17025 guidelines.
  • ISO/IEC 17025 : 2005Ministry of Environment & Forests (MoEF), India
  • Bureau of Indian Standards (BIS), India
  • Export Inspection Council (EIC), India
  • AGMARK, IndiaGold & Silver Assaying & Hallmarking Center (approved by Bureau of Indian Standards)
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.